These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23874744)

  • 1. Yin Yang gene expression ratio signature for lung cancer prognosis.
    Xu W; Banerji S; Davie JR; Kassie F; Yee D; Kratzke R
    PLoS One; 2013; 8(7):e68742. PubMed ID: 23874744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10-Gene Yin Yang Expression Ratio Signature for Stage IA and IB Non-Small Cell Lung Cancer.
    Xu W; Jia G; Davie JR; Murphy L; Kratzke R; Banerji S
    J Thorac Oncol; 2016 Dec; 11(12):2150-2160. PubMed ID: 27498386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 16 Yin Yang gene expression ratio signature for ER+/node- breast cancer.
    Xu W; Jia G; Cai N; Huang S; Davie JR; Pitz M; Banerji S; Murphy L
    Int J Cancer; 2017 Mar; 140(6):1413-1424. PubMed ID: 27925180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes and functions from breast cancer signatures.
    Huang S; Murphy L; Xu W
    BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Opposing Effects (Yin and Yang) Determine Cancer Progression.
    Huang S; Kurubanjerdjit N; Xu W
    Crit Rev Oncog; 2017; 22(1-2):143-155. PubMed ID: 29604942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma.
    Wan YW; Beer DG; Guo NL
    Lung Cancer; 2012 Apr; 76(1):98-105. PubMed ID: 22047960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncogenic role of Yin Yang 1.
    Zhang Q; Stovall DB; Inoue K; Sui G
    Crit Rev Oncog; 2011; 16(3-4):163-97. PubMed ID: 22248053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction.
    Wan YW; Sabbagh E; Raese R; Qian Y; Luo D; Denvir J; Vallyathan V; Castranova V; Guo NL
    PLoS One; 2010 Aug; 5(8):e12222. PubMed ID: 20808922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yin Yang 2: the great unknown within the Yin Yang 1 regulatory network.
    Klar M
    Crit Rev Oncog; 2011; 16(3-4):239-43. PubMed ID: 22248057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer.
    Qi L; Chen L; Li Y; Qin Y; Pan R; Zhao W; Gu Y; Wang H; Wang R; Chen X; Guo Z
    Brief Bioinform; 2016 Mar; 17(2):233-42. PubMed ID: 26254430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1.
    Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
    DNA Cell Biol; 2017 Nov; 36(11):947-958. PubMed ID: 28972861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
    Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Analysis Reveals Subtype-Specific Regulatory Determinants in Triple Negative Breast Cancer.
    Huang S; Xu W; Hu P; Lakowski TM
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30974831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Yin and Yang of YY1 in tumor growth and suppression.
    Khachigian LM
    Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance.
    Lee ES; Kim MJ; Park SC; Hur BY; Hyun JH; Chang HJ; Baek JY; Kim SY; Kim DY; Oh JH
    Eur Radiol; 2018 Feb; 28(2):496-505. PubMed ID: 28786006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.
    Zhu CQ; Ding K; Strumpf D; Weir BA; Meyerson M; Pennell N; Thomas RK; Naoki K; Ladd-Acosta C; Liu N; Pintilie M; Der S; Seymour L; Jurisica I; Shepherd FA; Tsao MS
    J Clin Oncol; 2010 Oct; 28(29):4417-24. PubMed ID: 20823422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1.
    Fang M; Huang W; Wu X; Gao Y; Ou J; Zhang X; Li Y
    Anat Rec (Hoboken); 2019 Feb; 302(2):258-268. PubMed ID: 30290400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
    Zengin T; Önal-Süzek T
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.